RxDoctor Payments Data

David Barclay, PA

Physician Assistant · Meridian, IDNPI 1285803445

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,375 of the $11,237 with a category attached, or 83.4%. 22 manufacturers reported payments, led by AbbVie at 32.6% of the total. 2025 is the largest year on record at $3,681, 3.6 times the $1,017 reported in 2021. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,237in general payments, 2019–2025

Across 330 payments — averaging $34.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Arcutis Biotherapeutics, Inc.$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Johnson & Johnson$804
  • Novartis$702
  • Galderma Laboratories, L.p.$479
  • plus $3K from 16 others

What the payments were for

  • Consulting fees$1,35012%
  • Food & beverage$9,37583%
  • Education$5125%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,237 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$131,632
Medicare patients
695
Services billed
3,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa15$311,402
Humira(Cf) PenAdalimumab12$135,982
Dupixent PenDupilumab35$135,952
Calcipotriene30$6,817
Tacrolimus32$4,810
Betamethasone Dipropionate51$2,598
Clobetasol Propionate65$2,500
Fluorouracil19$1,660
Fluocinonide23$1,479
Ketoconazole99$1,242
Doxycycline Hyclate46$1,226
Metronidazole19$1,225
Triamcinolone Acetonide107$835
Dapsone11$832
CiclopiroxCiclopirox Olamine29$813

Paid to pharmacies, not to this prescriber.

Other physician assistant in Meridian

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →